Addisonian Crisis
Verified clinical guidelines and emergency management protocols.
Protocol Content
Navigation
ADRENAL CRISIS (ADDISONIAN CRISIS) โ EMERGENCY PROTOCOL
CLINICAL MANAGEMENT GUIDELINE โ INDIA
๐จ MEDICAL EMERGENCY | IMMEDIATE TREATMENT REQUIRED
Mortality: 0.5-2% per crisis episode; Higher if delayed treatment
This is a CLINICAL diagnosis โ TREAT FIRST, Confirm Later
Do NOT wait for lab results to initiate treatment
๐ฐ SYMBOL LEGEND
| Symbol | Meaning |
| ๐จ | Emergency / Critical |
| โ | Recommended / First-line |
| โ ๏ธ | Caution / Important |
| โ | Contraindicated / Avoid |
| ๐ | Drug |
| ๐ฎ๐ณ | India-specific |
| โฑ๏ธ | Time-critical |
SECTION 1: RECOGNITION
1.1 DEFINITION
๐จ Adrenal Crisis (Addisonian Crisis) = Life-threatening medical emergency due to acute cortisol deficiency, characterized by:
-
- Severe hypotension / Shock (refractory to fluids and vasopressors)
- Volume depletion
- Often with precipitating event
๐ Can occur in KNOWN adrenal insufficiency (most common) OR as FIRST presentation
1.2 WHO IS AT RISK?
Patients with Known Adrenal Insufficiency
| Condition |
|
Primary adrenal insufficiency (Addisonโs disease)
|
|
Secondary adrenal insufficiency (Pituitary disease)
|
|
Tertiary adrenal insufficiency (Chronic steroid use → HPA suppression)
|
|
Bilateral adrenalectomy
|
|
Congenital adrenal hyperplasia (CAH)
|
Patients Without Known Diagnosis (First Presentation)
| Scenario |
| Undiagnosed Addisonโs disease |
| Pituitary apoplexy |
| Bilateral adrenal hemorrhage (Waterhouse-Friderichsen) |
| Acute illness in patient with unrecognized adrenal insufficiency |
1.3 PRECIPITANTS โ THE TRIGGER
๐ Crisis is almost ALWAYS precipitated by a stressor in patients with adrenal insufficiency
| ๐จ Common Precipitants |
|
Infection (most common) โ Gastroenteritis, Respiratory, UTI, Sepsis
|
|
Non-compliance / Discontinuation of glucocorticoid replacement
|
|
Inadequate stress dosing during illness/surgery
|
|
Vomiting / Diarrhea (cannot absorb oral steroids)
|
|
Surgery / Trauma without adequate steroid cover
|
|
Severe physical stress
|
|
Emotional stress (less common precipitant)
|
| Other Precipitants |
| Adrenal hemorrhage (anticoagulants, sepsis, trauma) |
| Pituitary apoplexy |
| Drugs: Ketoconazole, Etomidate, Rifampicin (↑ cortisol metabolism), Phenytoin, Checkpoint inhibitors |
| Pregnancy / Labor |
| Burns |
| Myocardial infarction |
| Hyperthyroidism treatment (↑ cortisol clearance) |
1.4 CAUSES OF ADRENAL INSUFFICIENCY LEADING TO CRISIS
Primary Adrenal Insufficiency
| Cause | Notes |
|
Autoimmune adrenalitis
|
Most common in developed countries |
|
Tuberculosis
|
Most common in India
|
|
Adrenal hemorrhage
|
Anticoagulants, Sepsis (Waterhouse-Friderichsen), Trauma |
|
Bilateral adrenalectomy
|
|
|
Metastatic disease
|
Lung, Breast, Melanoma |
|
Infections
|
Fungal (Histoplasma), HIV/CMV |
|
Congenital adrenal hyperplasia
|
|
|
Adrenoleukodystrophy
|
|
|
Drugs
|
Ketoconazole, Etomidate |
Secondary/Tertiary Adrenal Insufficiency
| Cause | Notes |
|
Chronic glucocorticoid therapy
|
Most common cause overall
|
|
Pituitary tumors / Surgery / Radiation
|
|
|
Pituitary apoplexy
|
Acute |
|
Sheehan syndrome
|
Postpartum pituitary necrosis |
|
Hypophysitis
|
Autoimmune, Checkpoint inhibitor-induced |
|
Hypothalamic disease
|
|
|
Traumatic brain injury
|
SECTION 2: CLINICAL FEATURES
2.1 CARDINAL FEATURES
| ๐จ Feature | Description |
|
Hypotension / Shock
|
Often refractory to fluids and vasopressors |
|
Volume depletion
|
Dehydration |
|
Altered consciousness
|
Confusion, Lethargy, Obtundation, Coma |
|
Abdominal symptoms
|
Pain, Nausea, Vomiting (may mimic acute abdomen) |
|
Precipitating event
|
Usually identifiable |
2.2 SYMPTOMS
Cardiovascular
| Symptom |
|
Dizziness / Lightheadedness
|
|
Syncope / Near-syncope
|
|
Palpitations (compensatory tachycardia)
|
Gastrointestinal
| Symptom | Notes |
|
Nausea
|
Very common |
|
Vomiting
|
May precipitate crisis (canโt absorb oral meds) |
|
Abdominal pain
|
Can be severe; May mimic acute abdomen |
|
Diarrhea
|
|
|
Anorexia
|
Neurological
| Symptom |
|
Weakness (profound)
|
|
Fatigue (severe)
|
|
Confusion
|
|
Lethargy
|
Other
| Symptom |
|
Fever (if infection precipitant; Or due to crisis itself)
|
|
Leg cramps / Myalgia (electrolyte disturbances)
|
2.3 SIGNS
Vital Signs
| Sign | Finding |
|
Blood pressure
|
↓↓ Hypotension; Often < 90/60 mmHg |
|
Postural hypotension
|
Marked drop on standing |
|
Heart rate
|
↑ Tachycardia (compensatory) |
|
Temperature
|
↑ Fever (infection) OR ↓ Hypothermia |
|
Respiratory rate
|
May be increased |
General Examination
| Sign | Notes |
|
Dehydration
|
Dry mucous membranes, Reduced skin turgor, Sunken eyes |
|
Shock
|
Cold peripheries, Delayed capillary refill, Weak pulse |
|
Altered consciousness
|
Confusion → Obtundation → Coma |
|
Hyperpigmentation
|
PRIMARY AI only โ Palmar creases, Buccal mucosa, Scars, Pressure points
|
|
Vitiligo
|
May be present (autoimmune association) |
|
Abdominal tenderness
|
May mimic acute abdomen |
|
Absent axillary/pubic hair
|
Women with chronic AI |
Signs by Underlying Cause
| Sign | Suggests |
|
Hyperpigmentation
|
PRIMARY adrenal insufficiency (high ACTH) |
|
NO hyperpigmentation
|
SECONDARY/TERTIARY (low ACTH) |
|
Visual field defect
|
Pituitary tumor |
|
Bilateral adrenal mass/hemorrhage on imaging
|
Adrenal hemorrhage/metastases |
|
Signs of underlying infection
|
Precipitant |
2.4 CLASSIC PRESENTATION SCENARIOS
Scenario 1: Known Addisonโs Disease + Illness
| Features |
| Patient with known primary AI |
| Develops gastroenteritis (vomiting, diarrhea) |
| Unable to take/absorb oral hydrocortisone |
| Develops hypotension, Weakness, Confusion |
|
Diagnosis: Adrenal crisis due to GI illness
|
Scenario 2: Patient on Chronic Steroids + Surgery
| Features |
| Patient on long-term prednisolone for RA/Asthma |
| Undergoes surgery WITHOUT stress dose steroids |
| Post-operatively develops hypotension, Shock |
| Refractory to fluids and vasopressors |
|
Diagnosis: Adrenal crisis due to inadequate steroid cover
|
Scenario 3: First Presentation
| Features |
| Previously healthy (or chronic fatigue, Weight loss) |
| Develops severe infection |
| Presents with shock, Hyperpigmentation |
| Hypotension refractory to treatment |
| Hyponatremia, Hyperkalemia |
|
Diagnosis: Adrenal crisis as first presentation of Addisonโs
|
Scenario 4: Waterhouse-Friderichsen Syndrome
| Features |
| Severe sepsis (especially Meningococcal) |
| Bilateral adrenal hemorrhage |
| Rapid deterioration, Purpura, DIC |
| Refractory shock |
|
Diagnosis: Adrenal crisis due to adrenal hemorrhage
|
2.5 CLINICAL CLUES TO ADRENAL CRISIS
| ๐ฉ Red Flags โ Think Adrenal Crisis If: |
|
Shock refractory to fluids and vasopressors
|
|
Hypotension + Hyponatremia + Hyperkalemia
|
|
Hyperpigmentation
|
|
History of adrenal/pituitary disease
|
|
History of chronic steroid use
|
|
Recent steroid withdrawal
|
|
Hypoglycemia (especially with hypotension)
|
|
Unexplained fever + Hypotension
|
|
Abdominal pain + Hypotension + Confusion
|
SECTION 3: DIAGNOSIS
3.1 CLINICAL DIAGNOSIS
| ๐จ CRITICAL PRINCIPLE |
|
ADRENAL CRISIS IS A CLINICAL DIAGNOSIS
|
|
TREAT FIRST โ Confirm Later
|
| Do NOT wait for lab results |
| Delay in treatment = Increased mortality |
Clinical Diagnostic Criteria
| Criteria |
| Acute deterioration in health status |
|
PLUS Hypotension (SBP < 100 mmHg) or Shock
|
|
PLUS Features that resolve with parenteral glucocorticoid
|
|
WITH Underlying adrenal insufficiency (known or suspected)
|
3.2 LABORATORY FINDINGS
Electrolytes
| Finding | Mechanism | Notes |
|
Hyponatremia
|
↓ Aldosterone (Na+ loss); ↓ Cortisol (↑ ADH) | Common in PRIMARY |
|
Hyperkalemia
|
↓ Aldosterone (K+ retention) | Common in PRIMARY |
|
Metabolic acidosis
|
↓ Aldosterone (H+ retention) | |
|
Normal electrolytes
|
May occur in SECONDARY (aldosterone intact) |
Glucose
| Finding | Notes |
|
Hypoglycemia
|
↓ Gluconeogenesis; More common in children and secondary AI |
Renal Function
| Finding | Mechanism |
|
Elevated urea
|
Dehydration; Prerenal |
|
Elevated creatinine
|
Dehydration; Prerenal |
Other
| Test | Finding |
|
Calcium
|
May be elevated |
|
CBC
|
Eosinophilia; Lymphocytosis; Anemia (chronic) |
|
TSH
|
May be elevated (cortisol needed for TSH suppression) |
3.3 HORMONAL CONFIRMATION (When Stable)
๐ Draw blood for cortisol BEFORE giving steroids if possible, but DO NOT DELAY TREATMENT
Cortisol
| Test | Interpretation |
|
Random cortisol
|
Should be HIGH in acute illness/stress |
| < 3 μg/dL (83 nmol/L) = AI very likely | |
| < 10 μg/dL (276 nmol/L) in critically ill = AI likely | |
| < 15-18 μg/dL (414-500 nmol/L) in acute stress = Inappropriate | |
| > 18-20 μg/dL (500-550 nmol/L) = AI unlikely |
ACTH
| Finding | Interpretation |
|
↑↑ High ACTH + ↓ Cortisol
|
PRIMARY adrenal insufficiency |
|
↓ or Normal ACTH + ↓ Cortisol
|
SECONDARY/TERTIARY (Central) |
Confirmatory Testing (Once Stable)
| Test | Protocol |
|
Short Synacthen Test (ACTH Stimulation)
|
Give Synacthen 250 μg IV/IM; Measure cortisol at 0, 30, 60 min |
|
Interpretation
|
Peak cortisol < 18-20 μg/dL (500 nmol/L) = AI confirmed |
3.4 DISTINGUISHING PRIMARY VS SECONDARY AI
| Feature | Primary AI | Secondary AI |
|
ACTH
|
↑↑ | ↓ or Normal |
|
Aldosterone
|
↓ |
Normal
|
|
Hyponatremia
|
โ Common | May occur (dilutional) |
|
Hyperkalemia
|
โ Common | โ Absent (aldosterone intact) |
|
Hyperpigmentation
|
โ Present | โ Absent |
|
Salt craving
|
โ Present | โ Absent |
3.5 ADDITIONAL INVESTIGATIONS
| Investigation | Purpose |
|
ECG
|
Hyperkalemia changes; Arrhythmias |
|
CXR
|
Infection; Small heart (chronic AI) |
|
Blood cultures
|
Infection workup |
|
Urine analysis/culture
|
UTI |
|
Blood glucose
|
Hypoglycemia |
|
CT Adrenals
|
Hemorrhage, Calcification (TB), Masses |
|
CT/MRI Pituitary
|
If secondary AI suspected |
SECTION 4: MANAGEMENT โ OVERVIEW
4.1 Treatment Principles
๐จ Adrenal Crisis Management
โฑ๏ธ Time-Critical: Treat Immediately
Do NOT wait for laboratory results before starting treatment.
Step 1: IV Hydrocortisone
๐ 100 mg IV bolus immediately
Then 50โ100 mg IV every 6โ8 hours
OR 200 mg continuous IV infusion over 24 hours
Step 2: IV Fluids
Administer 0.9% Normal Saline for aggressive fluid resuscitation
-
1 liter in the first hour
-
4โ6 liters during the first 24 hours
Step 3: Treat Hypoglycemia
Check blood glucose levels.
If hypoglycemia is present, give IV Dextrose immediately.
Step 4: Identify and Treat Precipitating Cause
Identify the underlying trigger.
Most common cause: Infection
Start appropriate antibiotics if infection is suspected.
Step 5: Monitor and Taper
Closely monitor:
-
Vital signs
-
Electrolytes
-
Blood glucose
Once the patient is clinically stable, transition to oral maintenance steroid therapy.
4.2 KEY POINTS
| ๐จ Critical Points |
|
Hydrocortisone is life-saving โ Give IMMEDIATELY
|
|
High-dose hydrocortisone has mineralocorticoid activity โ No need for fludrocortisone acutely
|
|
Aggressive IV fluids โ These patients are severely volume depleted
|
|
Treat the precipitant โ Usually infection
|
|
Do NOT use dexamethasone if you need to do ACTH stim test later (dexamethasone doesnโt cross-react with cortisol assay; hydrocortisone does โ but treatment takes priority)
|
SECTION 5: STEP-BY-STEP MANAGEMENT
STEP 1: HYDROCORTISONE โ IMMEDIATE
5.1 Initial Bolus
| ๐ Drug | Dose | Route | Timing |
|
Hydrocortisone sodium succinate
|
100 mg
|
IV bolus
|
IMMEDIATELY
|
5.2 Maintenance
| Regimen | Dose |
|
Intermittent bolus
|
50-100 mg IV q6-8h
|
|
OR Continuous infusion
|
200 mg IV over 24 hours (8.3 mg/hr)
|
5.3 Why Hydrocortisone?
| Advantage |
| โ Has BOTH glucocorticoid AND mineralocorticoid activity |
| โ At high doses (≥ 50 mg), mineralocorticoid effect is sufficient |
| โ No need for separate fludrocortisone in acute phase |
| โ Rapid onset |
| โ Widely available |
5.4 Alternative Glucocorticoids (If Hydrocortisone Unavailable)
| ๐ Drug | Dose | Notes |
|
Dexamethasone
|
4 mg IV
|
โ ๏ธ NO mineralocorticoid activity; May need fludrocortisone in primary AI |
| โ Use if ACTH stim test planned (doesnโt interfere with cortisol assay) | ||
|
Methylprednisolone
|
40 mg IV
|
Minimal mineralocorticoid activity |
|
Prednisolone
|
25 mg IV/PO
|
Less preferred; Oral absorption may be impaired |
5.5 Glucocorticoid Equivalence
| Drug | Equivalent Dose | Mineralocorticoid Activity |
| Hydrocortisone 100 mg | โ | โ Yes |
| Prednisolone 25 mg | ≈ | Minimal |
| Methylprednisolone 20 mg | ≈ | None |
| Dexamethasone 4 mg | ≈ | None |
STEP 2: IV FLUID RESUSCITATION
5.6 Fluid Choice
| ๐ง Fluid | Recommendation |
|
0.9% Normal Saline
|
โ
First-line
|
|
5% Dextrose in Normal Saline
|
โ If hypoglycemic |
5.7 Fluid Volume
| Time | Volume |
|
First hour
|
1000 mL (rapid bolus)
|
|
First 4-6 hours
|
2-3 L
|
|
First 24 hours
|
4-6 L (guided by response)
|
5.8 Why Aggressive Fluids?
| Rationale |
| Patients are severely volume depleted |
| Aldosterone deficiency (PRIMARY AI) → Sodium and water loss |
| Vomiting/diarrhea worsen dehydration |
| Hypotension is primarily due to volume depletion |
5.9 Fluid Monitoring
| Monitor |
|
Urine output โ Target > 0.5 mL/kg/hr
|
|
Blood pressure โ Target MAP > 65 mmHg
|
|
Heart rate โ Should decrease with resuscitation
|
|
Clinical perfusion โ Capillary refill, Skin temperature
|
|
โ ๏ธ Avoid overload in elderly/cardiac patients
|
STEP 3: CORRECT HYPOGLYCEMIA
5.10 Management
| If Hypoglycemic |
|
50 mL of 50% Dextrose IV bolus (25 g)
|
|
OR 100-200 mL of 25% Dextrose
|
|
OR 500 mL of 10% Dextrose
|
|
Switch to Dextrose-containing maintenance fluids (D5NS)
|
| Monitor glucose q1-2 hours initially |
STEP 4: IDENTIFY AND TREAT PRECIPITANT
5.11 Search for Precipitant
| Investigation |
| History: Infection, Missed doses, Surgery, Trauma |
| Examination: Source of infection |
| Blood cultures |
| Urine analysis and culture |
| CXR |
| Other directed investigations |
5.12 Treat Infection
| If Infection Suspected |
|
Empiric broad-spectrum antibiotics
|
| Do NOT delay antibiotics |
| Adjust based on culture results |
| Common Regimens |
|
Community-acquired: Ceftriaxone 2 g IV + Azithromycin (if respiratory)
|
|
Urinary source: Ceftriaxone or Fluoroquinolone
|
|
Sepsis/Unknown: Piperacillin-tazobactam or Meropenem
|
STEP 5: ADDITIONAL MEASURES
5.13 Vasopressors
| When to Use |
|
If hypotension persists despite adequate fluids and hydrocortisone
|
|
๐ Noradrenaline โ First-line vasopressor
|
| Start at 0.05-0.1 μg/kg/min; Titrate to MAP > 65 mmHg |
| โ ๏ธ Important |
|
Hypotension in adrenal crisis is often refractory to vasopressors UNTIL glucocorticoid given
|
| Response to vasopressors improves after hydrocortisone |
5.14 Correct Electrolyte Abnormalities
| Abnormality | Management |
|
Hyponatremia
|
Usually corrects with IV NS + Hydrocortisone; Do NOT use hypertonic saline unless severe/symptomatic |
|
Hyperkalemia
|
Usually corrects with IV NS + Hydrocortisone; Standard hyperkalemia treatment if severe (Calcium gluconate, Insulin-dextrose, Salbutamol) |
5.15 Monitor for Complications
| Complication | Management |
|
Arrhythmias (Hyperkalemia)
|
ECG monitoring; Treat hyperkalemia |
|
Seizures (Hypoglycemia, Hyponatremia)
|
Correct glucose and sodium; Benzodiazepines |
|
Shock (Refractory)
|
Vasopressors; Ensure adequate steroid dose |
SECTION 6: MONITORING
6.1 ACUTE PHASE MONITORING
| Parameter | Frequency | Target |
|
Blood pressure
|
Continuous / q15 min initially | SBP > 100; MAP > 65 |
|
Heart rate
|
Continuous | Decreasing (compensation reducing) |
|
Urine output
|
Hourly | > 0.5 mL/kg/hr |
|
Oxygen saturation
|
Continuous | > 94% |
|
Temperature
|
q2-4 hours | Monitor for fever (infection) |
|
Glucose
|
q1-2 hours initially | > 70 mg/dL |
|
Sodium
|
q6-12 hours | Gradual normalization |
|
Potassium
|
q6-12 hours | < 5.5 mEq/L |
|
Mental status
|
Frequent | Improving |
6.2 EXPECTED CLINICAL RESPONSE
| Time | Expected Response |
|
1-2 hours
|
Blood pressure improving |
|
4-6 hours
|
Significant hemodynamic improvement |
|
12-24 hours
|
Clinical stabilization |
|
24-72 hours
|
Resolution of acute crisis |
|
Days
|
Electrolytes normalizing |
6.3 SIGNS OF IMPROVEMENT
| โ Improving |
| Blood pressure rising |
| Heart rate decreasing |
| Urine output increasing |
| Mental status clearing |
| Sodium rising |
| Potassium falling |
| Glucose stable |
6.4 SIGNS OF NON-RESPONSE / DETERIORATION
| ๐จ Worsening |
| Persistent hypotension despite treatment |
| Worsening mental status |
| Oliguria / Anuria |
| Worsening metabolic acidosis |
| Uncontrolled hyperkalemia |
| Action |
| Ensure adequate hydrocortisone dose |
| Ensure adequate fluid resuscitation |
| Consider alternative diagnosis |
| Escalate care (ICU if not already) |
| Look for uncontrolled precipitant |
SECTION 7: TAPERING AND TRANSITION
7.1 WHEN TO TAPER
| Criteria to Begin Taper |
| Hemodynamically stable |
| Eating and drinking |
| Precipitant controlled |
| Electrolytes improving |
|
Usually after 24-72 hours
|
7.2 TAPERING PROTOCOL
| Day | Hydrocortisone Dose |
|
Day 1 (Crisis)
|
100 mg IV bolus → 50-100 mg q6-8h |
|
Day 2
|
50 mg IV/PO q6-8h (150-200 mg/day) |
|
Day 3
|
25-50 mg PO q6-8h (75-150 mg/day) |
|
Day 4
|
20 mg AM + 10 mg Noon + 10 mg PM (40 mg/day) |
|
Day 5
|
20 mg AM + 10 mg PM (30 mg/day) |
|
Day 6+
|
Return to maintenance (15-25 mg/day) |
7.3 TRANSITION TO ORAL MAINTENANCE
Oral Hydrocortisone Regimen
| ๐ Hydrocortisone | Typical Maintenance |
|
Dose
|
15-25 mg/day |
|
Regimen
|
10 mg AM + 5 mg Noon + 5 mg Late afternoon |
|
OR
|
15 mg AM + 5 mg Afternoon |
Add Fludrocortisone (PRIMARY AI Only)
| ๐ Fludrocortisone | Dose |
|
When to start
|
Once hydrocortisone < 50 mg/day |
|
Dose
|
0.05-0.2 mg once daily (usually 0.1 mg)
|
|
Not needed in
|
Secondary/Tertiary AI (aldosterone intact) |
7.4 DISCHARGE CRITERIA
| โ Ready for Discharge |
| Hemodynamically stable on oral medication |
| Tolerating oral intake |
| Precipitant treated/controlled |
| Electrolytes stable |
| Patient/Family educated on sick day rules |
| Emergency injection kit provided |
| Medical alert identification arranged |
| Follow-up appointment scheduled |
SECTION 8: PREVENTION OF FUTURE CRISES
8.1 SICK DAY RULES โ PATIENT EDUCATION
Mild Illness (Cold, Minor Infection, Low-grade Fever)
| Rule |
|
DOUBLE the usual hydrocortisone dose
|
| Continue fludrocortisone unchanged |
| Increase fluid and salt intake |
| Continue until recovered |
| Return to normal dose when well |
Moderate Illness (Higher Fever, Vomiting, Diarrhea)
| Rule |
|
TRIPLE the usual hydrocortisone dose
|
|
If unable to keep oral meds down → Injectable hydrocortisone
|
| Seek medical attention |
Severe Illness / Emergency
| ๐จ Rule |
|
100 mg Hydrocortisone IM/IV immediately
|
|
Then 50-100 mg every 6-8 hours
|
|
Seek emergency medical care
|
8.2 STRESS DOSING FOR PROCEDURES
| Procedure | Recommendation |
|
Minor (Dental work)
|
Double dose on morning of procedure |
|
Moderate (Endoscopy)
|
50 mg IV/IM before procedure; Double oral × 24-48h |
|
Major surgery
|
100 mg IV pre-op → 50-100 mg IV q8h → Taper over 3-5 days |
8.3 EMERGENCY INJECTION KIT
| Every Patient MUST Have |
|
Hydrocortisone injection kit (100 mg)
|
|
Syringes and needles
|
|
Instructions for self-injection / Family injection
|
|
Train patient AND family on IM injection
|
Self-Injection Technique
| Step | Action |
| 1 | Reconstitute hydrocortisone (if powder) |
| 2 | Draw up 100 mg |
| 3 | Inject into outer thigh (IM) |
| 4 |
Call for emergency help
|
| 5 | Lie down; Do not drive |
8.4 MEDICAL IDENTIFICATION
| Every Patient MUST Have |
|
Medical alert bracelet or necklace
|
|
Emergency card in wallet
|
|
Phone ICE contact with diagnosis
|
Card Should State
| Information |
| โI have ADRENAL INSUFFICIENCYโ |
| โIn emergency, I need HYDROCORTISONE 100 mg IV/IM immediatelyโ |
| โDo NOT wait for blood testsโ |
| Emergency contact details |
| Doctorโs contact |
8.5 PATIENT EDUCATION CHECKLIST
| โ Every Patient Must Know |
|
Never stop steroids suddenly
|
|
Double dose if unwell
|
|
Triple dose if moderately ill
|
|
Use injection if vomiting / Canโt take oral
|
|
Seek medical help if not improving
|
|
Always carry emergency injection
|
|
Wear medical alert identification
|
|
Inform all healthcare providers
|
|
Carry steroid card
|
SECTION 9: DRUG DOSES โ QUICK REFERENCE
9.1 ACUTE CRISIS MANAGEMENT
| Step | Drug | Dose |
|
1
|
๐ Hydrocortisone
|
100 mg IV bolus → 50-100 mg q6-8h OR 200 mg/24h infusion
|
|
2
|
๐ง 0.9% Normal Saline
|
1L in first hour → 4-6L in 24h
|
|
3
|
๐ Dextrose
|
D50 50 mL IV if hypoglycemic
|
|
4
|
Antibiotics
|
Empiric if infection suspected |
|
5
|
๐ Noradrenaline
|
0.05-0.1 μg/kg/min if refractory hypotension |
9.2 ALTERNATIVE GLUCOCORTICOIDS
| Drug | Dose | Notes |
|
Dexamethasone
|
4 mg IV q12h | No mineralocorticoid effect |
|
Methylprednisolone
|
40 mg IV q12h | Minimal mineralocorticoid effect |
|
Prednisolone
|
25 mg PO q6h | If IV unavailable |
9.3 MAINTENANCE THERAPY
| Drug | Dose |
|
๐ Hydrocortisone
|
15-25 mg/day in divided doses |
|
๐ Fludrocortisone (Primary AI only)
|
0.05-0.2 mg once daily |
9.4 SICK DAY DOSING
| Severity | Hydrocortisone Dose |
|
Mild illness
|
2× usual dose
|
|
Moderate illness
|
3× usual dose
|
|
Severe / Vomiting
|
100 mg IM/IV
|
9.5 SURGICAL STRESS DOSING
| Surgery | Pre-op | Intra/Post-op |
|
Minor
|
Double oral | Double × 24h |
|
Moderate
|
50 mg IV | Double × 24-48h |
|
Major
|
100 mg IV | 50-100 mg IV q8h → Taper |
SECTION 10: SPECIAL SITUATIONS
10.1 ADRENAL CRISIS IN PREGNANCY
Key Points
| Consideration |
| Adrenal crisis can occur in pregnancy |
| Diagnosis can be challenging (Physiological changes mimic some features) |
|
Hydrocortisone is SAFE in pregnancy
|
|
Fludrocortisone is SAFE in pregnancy
|
| May need higher maintenance doses in 3rd trimester |
|
Labor/Delivery: Stress dose hydrocortisone required
|
Labor and Delivery Protocol
| Phase | Dose |
|
Early labor
|
Hydrocortisone 25-50 mg IV |
|
Active labor
|
Hydrocortisone 100 mg IV |
|
Delivery
|
Continue 50-100 mg IV q6-8h |
|
Post-delivery
|
Taper over 24-72 hours |
10.2 ADRENAL CRISIS IN CHILDREN
Key Points
| Consideration |
|
Hypoglycemia more common in children
|
| Weight-based dosing required |
| CAH is common cause in infants |
| Family education critical |
Pediatric Dosing
| Drug | Dose |
|
Hydrocortisone
|
50-100 mg/m² IV bolus (or 2-4 mg/kg, max 100 mg)
|
|
Maintenance
|
50-100 mg/m²/day IV in divided doses
|
|
Fluids
|
20 mL/kg NS bolus → Maintenance
|
|
Dextrose
|
2-4 mL/kg of D25 if hypoglycemic
|
10.3 ADRENAL CRISIS IN PATIENTS ON ANTICOAGULANTS
Suspect Adrenal Hemorrhage
| Clues |
| Patient on warfarin/heparin/DOACs |
| Sudden onset of: Abdominal/Flank pain, Hypotension, Fever |
| Falling hematocrit |
| CT: Bilateral adrenal hemorrhage |
Management
| Action |
|
Treat crisis standard protocol (Hydrocortisone + Fluids)
|
|
Reverse anticoagulation if severe bleeding
|
|
CT Adrenals to confirm
|
|
Will likely need lifelong steroid replacement
|
10.4 BILATERAL ADRENALECTOMY
Key Points
| Consideration |
| 100% dependent on exogenous steroids |
| High risk of crisis |
|
MUST have emergency injection kit
|
| Education critical |
10.5 SECONDARY ADRENAL INSUFFICIENCY
Key Differences
| Feature | Primary AI | Secondary AI |
|
Aldosterone
|
↓ | Normal |
|
Hyperkalemia
|
Yes | No |
|
Hyperpigmentation
|
Yes | No |
|
Fludrocortisone needed
|
Yes |
No
|
Management
| Same as primary EXCEPT: |
|
No fludrocortisone needed (aldosterone intact)
|
| Usually less severe hyponatremia |
| Consider other pituitary hormone deficiencies |
10.6 STEROID WITHDRAWAL CRISIS
Scenario
| Features |
| Patient on chronic steroids (> 3 weeks) |
| Abruptly stops or rapidly tapers steroids |
| Develops fatigue, Hypotension, Nausea |
Management
| Action |
|
Same treatment as adrenal crisis
|
| Restart steroids |
| Slow, gradual taper when stable |
| May take months for HPA axis to recover |
SECTION 11: ๐ฎ๐ณ INDIA-SPECIFIC CONSIDERATIONS
11.1 COMMON CAUSES IN INDIA
| Cause | Notes |
|
Tuberculosis
|
Most common cause of primary AI in India
|
|
Autoimmune
|
Increasing, especially urban areas |
|
Chronic steroid use
|
Common; Often over-the-counter; Hidden in Ayurvedic preparations |
|
Post-TB
|
May have adrenal calcification |
11.2 DRUG AVAILABILITY
| Drug | Availability | Cost |
|
Hydrocortisone injection 100 mg
|
โ Widely available | โน30-100 |
|
Hydrocortisone oral 10/20 mg
|
โ Available | โน50-150/month |
|
Fludrocortisone 0.1 mg
|
โ ๏ธ Variable availability | โน200-400/month |
|
Dexamethasone injection
|
โ Widely available | โน10-50 |
|
Normal Saline
|
โ Widely available | โน30-50/L |
11.3 PRACTICAL CHALLENGES
| Challenge | Solution |
|
Fludrocortisone availability
|
Patients should maintain adequate supply; Alternative suppliers |
|
Non-compliance
|
Education; Family involvement; Regular follow-up |
|
Hidden steroids in Ayurvedic preparations
|
Detailed medication history; Educate patients |
|
Delayed presentation
|
Community awareness; Primary care education |
|
Cost of long-term therapy
|
Generic options; Government schemes |
11.4 TB-RELATED ADRENAL INSUFFICIENCY
Features
| Findings |
| Most common cause in India |
| May have history of TB or TB contact |
| CT may show: Enlarged adrenals (acute) or Calcified adrenals (chronic) |
| May need ATT if active TB |
Management
| Action |
| Standard crisis management |
|
Start ATT if active TB
|
|
โ ๏ธ Rifampicin increases cortisol metabolism โ May need higher hydrocortisone doses during ATT (increase by 50-100%)
|
| Adrenal function rarely recovers โ Usually lifelong replacement needed |
SECTION 12: SUMMARY TABLES
12.1 DIAGNOSTIC CLUES
| Finding | Suggests |
| Hypotension + Hyponatremia + Hyperkalemia | PRIMARY AI |
| Hypotension + Hyponatremia (without hyperkalemia) | SECONDARY AI |
| Hyperpigmentation | PRIMARY AI |
| Hypoglycemia + Hypotension | Adrenal crisis |
| Refractory shock | Think adrenal crisis |
12.2 IMMEDIATE MANAGEMENT CHECKLIST
| โ Action | Done |
|
Hydrocortisone 100 mg IV bolus
|
โ |
|
IV access × 2 large bore
|
โ |
|
0.9% NS 1L rapid infusion
|
โ |
|
Check glucose โ Treat if low
|
โ |
|
Blood samples: Cortisol, ACTH, U&E, Glucose, Cultures
|
โ |
|
ECG (Hyperkalemia)
|
โ |
|
Search for precipitant
|
โ |
|
Continuous monitoring
|
โ |
12.3 TREATMENT PROTOCOL SUMMARY
| Step | Intervention | Dose/Details |
|
1
|
Hydrocortisone IV | 100 mg bolus → 50-100 mg q6-8h |
|
2
|
IV Fluids | NS 1L/hr × 1h → 4-6L/24h |
|
3
|
Dextrose | If hypoglycemic |
|
4
|
Treat precipitant | Antibiotics if infection |
|
5
|
Monitor | BP, HR, UO, Glucose, Electrolytes |
|
6
|
Taper when stable | → Oral maintenance over 3-5 days |
12.4 SICK DAY RULES SUMMARY
| Illness Severity | Action |
|
Mild
|
Double oral dose |
|
Moderate
|
Triple oral dose |
|
Severe / Vomiting
|
100 mg IM/IV + Seek help |
12.5 PATIENT ESSENTIALS CHECKLIST
| โ Every Patient Must Have |
| Emergency hydrocortisone kit |
| Training on self-injection |
| Medical alert ID |
| Steroid card |
| Written sick day rules |
| Emergency contact numbers |
| Regular follow-up |
12.6 PRIMARY VS SECONDARY AI COMPARISON
| Feature | Primary AI | Secondary AI |
|
Site
|
Adrenal | Pituitary/Hypothalamus |
|
ACTH
|
↑↑ | ↓/Normal |
|
Aldosterone
|
↓ | Normal |
|
Hyperkalemia
|
Yes | No |
|
Hyperpigmentation
|
Yes | No |
|
Fludrocortisone
|
Needed | Not needed |
|
Salt craving
|
Yes | No |
๐ ABBREVIATIONS
| Abbreviation | Full Form |
| ACTH | Adrenocorticotropic Hormone |
| AI | Adrenal Insufficiency |
| ATT | Antitubercular Therapy |
| BP | Blood Pressure |
| CAH | Congenital Adrenal Hyperplasia |
| CMV | Cytomegalovirus |
| CT | Computed Tomography |
| D25/D50 | 25%/50% Dextrose |
| DIC | Disseminated Intravascular Coagulation |
| DOAC | Direct Oral Anticoagulant |
| ECG | Electrocardiogram |
| GI | Gastrointestinal |
| HIV | Human Immunodeficiency Virus |
| HPA | Hypothalamic-Pituitary-Adrenal |
| HR | Heart Rate |
| ICE | In Case of Emergency |
| ICU | Intensive Care Unit |
| IM | Intramuscular |
| IV | Intravenous |
| MAP | Mean Arterial Pressure |
| MRI | Magnetic Resonance Imaging |
| NS | Normal Saline |
| PO | Per Oral |
| RA | Rheumatoid Arthritis |
| SBP | Systolic Blood Pressure |
| TB | Tuberculosis |
| U&E | Urea and Electrolytes |
| UO | Urine Output |
| UTI | Urinary Tract Infection |
๐ KEY REFERENCES
| Source |
| Bornstein SR et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. JCEM 2016 |
| Puar TH et al. Adrenal Crisis: Still a Deadly Event in the 21st Century. Am J Med 2016 |
| Rushworth RL et al. Adrenal Crisis. NEJM 2019 |
| Husebye ES et al. Adrenal Insufficiency. Lancet 2021 |
| Bancos I et al. Diagnosis and Management of Adrenal Insufficiency. Lancet Diabetes Endocrinol 2015 |
| Hahner S et al. High Incidence of Adrenal Crisis in Educated Patients with Chronic Adrenal Insufficiency. JCEM 2015 |
| Harrisonโs Principles of Internal Medicine, 21st Edition |
| Williams Textbook of Endocrinology, 14th Edition |
Document Version: 1.0
Last Updated: December 2025
For: Healthcare Professionals Only
Related Guidelines: Addisonโs Disease (Primary Adrenal Insufficiency); Cushingโs Syndrome
Key Points:
-
- ๐จ TREAT FIRST โ Do NOT wait for labs
- ๐ Hydrocortisone 100 mg IV immediately
- ๐ง Aggressive IV Normal Saline
- ๐ Search for and treat precipitant
- ๐ Patient education and emergency kit are ESSENTIAL for prevention
Medical Advisory
Clinical guidelines are subject to change. Physicians should exercise their regular clinical judgment. This protocol does not replace individual institutional policies. Verified for Q1 2026.
Is this information helpful?
Help us improve our clinical database for the medical community.